EVIR Therapeutics
Modified dendritic cell vaccines for cancer immunotherapy
The purpose of the company is the development, manufacture, production and marketing of modified dendritic cell vaccines for cancer immunotherapy.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
EVIR Therapeutics
Modified dendritic cell vaccines for cancer immunotherapy
Headquarter:
Lausanne
Foundation Date:
October 2020
Technology:
- Biotech